11 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
% (Male) 51.8% (Female) 0.2% (Other / Non-binary) Embracing DE&I (Gender Representation) Enterprise-wide gender breakdown P L A N E T Reducing Scope 1 & 2 … GHG Emissions % reduction in Scope 1 & 2 GHG emissions The predicted impacts of severe climate change scenarios present a threat to global public
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Jun 23
Current report (foreign)
6:13am
scope 1 and 2 GHG emissions. In March 2023, we announced the opening of our first positive energy manufacturing support building in Singapore. At least
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:11am
, is expected to create up to 350,000 megawatt hours of renewable energy credits per year, accounting for approximately 20% of Takeda’s current enterprise scope … 1 and 2 GHG emissions. In March 2023, we announced the opening of our first positive energy manufacturing support building in Singapore. At least 115
6-K
TAK
Takeda Pharmaceutical Co
11 May 23
Current report (foreign)
6:07am
for approximately 20% of Takeda’s current enterprise scope 1 and 2 GHG emissions.
In March 2023, we announced the opening of our first positive energy
6-K
EX-99.1
0ii6xta 0iw22hrx
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
66rzr8qwa aptg01v
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
fyue5e6larhs5zd
28 May 21
Current report (foreign)
6:01am
6-K
rg1rko
11 May 21
Current report (foreign)
6:08am
6-K
EX-99.1
w8thrhagdcadg4m n3
17 Dec 20
Current report (foreign)
6:01am
6-K
EX-99.1
f9j4u60 uqpaz53eofm
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
- Prev
- 1
- Next